Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Lamivir Tablets*


May be acceptable

Not recommended
Lamivir Tablets* :
Type Medicine Non Marketed
Originator 3TC Tablets 150mg*
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Cipla
Responsible Party Cipla Ltd
Origin India
Manufacturer Cipla Ltd
Manufacturing Type G
Origin India
ATC J05AF05

Your comment will appear shortly after approval

Lamivir Tablets* :

Revision Date : 23/06/2014


Effect Frequency
ALT increased Very Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Blood creatine phosphokinase increased Common
Hepatic steatosis Not known
Hepatitis Not known
Hepatomegaly Not known
Lactic acidosis Not known
Muscle disorder Not known
Muscle spasms Not known
Myalgia Not known
Neuropathy peripheral Not known
Pancreatitis Not known
Paraesthesia (paresthesia) Not known
Pruritus Common
Rhabdomyolysis Not known
Skin rash Common
Thrombocytopenia (Thrombopenia) Not known

Different Units By MoH Code

Revision Date : no date

Lamivir Tablets*  MoH 2459 :
Form Tablet
Package Size Box of 60
Strength 150mg
Storage Condition <30°C None
NSSF ✘
Quarantine ✘
Reg. Number 208875/03
Submission date 01/01/2003
Registration Year 2005
Archived Date 02/10/2020


Price Comparison

● Country: Bahrain
● Package Size: 30
● Public Price: 4.13 BHD ( 981,841.42 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,1377 BHD ( 0.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info